AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2015
Dec 17, 2015
35424_dirs_2015-12-16_b8a2ab74-4347-41f0-bc10-a7b16837917e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2015-05-14
Reporting Person: Brandwein Steven F. (Interim Chief Financ. Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 12500 | Indirect |
Footnotes
F1: The shares reported as directly owned by Reporting Person in Table 1, Column 3, of the Reporting Person's original Form 3 filed May 14, 2015 were owned at the time of filing by the Steven Franklin Brandwein Living Trust. The purpose of this Amendment is to correct the form of ownership of those shares.
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19